Who owns DNA X, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of SONM from SEC Form 13F filings across 9 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 9 institutions disclosed 88,387 shares of DNA X, Inc. worth $453,763 — about 6.5% of shares outstanding; the largest disclosed holder is C2C Wealth Management, LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
9
13F holders
$453,763
value, 2026 filers
6.5%
of shares outstanding (88,387 sh)
1
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of SONM's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | C2C Wealth Management, LLC | 35,500 | $182,825 | 0.1% | 2.6% | +77.5% |
| 2 | BlackRock, Inc. | 14,006 | $72,131 | 0.0% | 1% | 0.0% |
| 3 | CITADEL ADVISORS LLCNEW | 12,740 | $65,101 | 0.0% | 0.9% | new |
| 4 | GEODE CAPITAL MANAGEMENT, LLC | 12,584 | $64,303 | 0.0% | 0.9% | -15.0% |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 5,901 | $30,154 | 0.0% | 0.4% | +20.6% |
| 6 | VANGUARD FIDUCIARY TRUST CO | 4,496 | $22,975 | 0.0% | 0.3% | 0.0% |
| 7 | UBS Group AG | 2,304 | $11,866 | 0.0% | 0.2% | -93.6% |
| 8 | Tower Research Capital LLC (TRC) | 642 | $3,306 | 0.0% | 0% | -2.9% |
| 9 | SBI Securities Co., Ltd. | 214 | $1,102 | 0.0% | 0% | 0.0% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.